
|Articles|August 1, 2016
- Pharmaceutical Executive-08-01-2016
- Volume 36
- Issue 8
Pharmaceutical Executive, August 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Pharm Exec's 15th Annual Industry Auditalmost 10 years ago
The Industry Audit: Fifteen Years Rightalmost 10 years ago
Dealmaking in 2016: It’s Complicatedalmost 10 years ago
Steady Hands: AmerisourceBergen's Peyton Howellalmost 10 years ago
Drug Shortages Raise Economic and Ethical Challengesalmost 10 years ago
The ‘Cure’-All for 21st Century Data Sharingalmost 10 years ago
European Pharma and the Unified Patent Courtalmost 10 years ago
An EU Referendum ... on Drug Pricing?almost 10 years ago
Country Report: HungaryAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5




